Medical/Pharmaceuticals

COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark

RARITAN, New Jersey, May 12, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its COVID-19 total antibody test received CE Mark. The test offers excellent perf...

2020-05-12 20:00 1867

QPS Announces Novel Coronavirus/COVID-19 Testing Capability

NEWARK, Delaware, May 12, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, announces a newly developed capability to conduct COVID-19 testing, available as ofMonday, May 11, 2020. QP...

2020-05-12 19:11 2807

Yili Group Donates Over 170,000 Face Masks to Thailand in Coronavirus Fight

BANGKOK, May 12, 2020 /PRNewswire/ -- Asia dairy giant Yili Group cooperates with its Thai subsidiary Chomthana and Thailand Siam Dragon Association to deliver 170,400 face masks and other anti-epidemic supplies to the Thai Ministry of Public Health,Royal Thai Police and Phuket Police Headquar...

2020-05-12 18:09 4164

Invivoscribe Submits LeukoStrat® CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners

SAN DIEGO, May 12, 2020 /PRNewswire/ -- Invivoscribe is pleased to announce that theirLeukoStrat® CDx FLT3 Mutation Assay was submitted to regulatory authorities inChina in April in support of the Astellas New Drug Application (NDA) submission of XOSPATA® (gilteritinib) for treatment of adult pat...

2020-05-12 18:00 2928

Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations

VISTA, California, May 12, 2020 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 se...

2020-05-12 11:19 3384

Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations

VISTA, California, May 12, 2020 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 se...

2020-05-12 10:00 2180

Leica Biosystems launches Aperio GT 450 DX in Asia enabling high volume clinical labs to scale up digital pathology operations

VISTA, California, May 12, 2020 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 se...

2020-05-12 10:00 1657

BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing

SHENZHEN, China, May 11, 2020 /PRNewswire/ -- BGI Genomics announced that its Real-time fluorescent RT-PCR kit for detecting 2019-nCoV has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process.  The EUL is a risk-based procedure...

2020-05-12 02:00 4607

Singlera Genomics Meets with FDA for Rapid Colon Cancer Assay and Has a Clear Path Forward

SAN DIEGO, May 11, 2020 /PRNewswire/ -- Singlera Genomics completed their second Pre-Submission Meeting with the US FDA Center for Devices and Radiological Health, Office of In Vitro Diagnostics onApril 21, 2020, after an initial Pre-Submission Meeting in the fall of 2019. The FDA provided clear ...

2020-05-12 01:39 1366

Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

-  Technology provides more tools to fight difficult-to-treat diseases  -  Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses -  Committed to ethical use of genome-editing technology DARMSTADT, Germany, May 11, 2020 /PRNewswire/ -- Merck, a leading...

2020-05-11 21:00 2813

Ortho Clinical Diagnostics and Quest Diagnostics to Broaden Availability of COVID-19 Antibody Testing

RARITAN, New Jersey, May 11, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics (NYSE: DGX), the world's leading provider of...

2020-05-11 20:00 4666

OssDsign Cranial PSI Granted Full Nationwide Reimbursement in Japan

STOCKHOLM, May 11, 2020 /PRNewswire/ -- OssDsign announces that the Ministry of Health, Labour and Welfare (MHLW) inJapan has granted full and nationwide reimbursement for OssDsign Cranial PSI. The decision came earlier than expected and will come into force in early June 2020.  Securing nationw...

2020-05-11 15:15 1727

Hangzhou Realy IgG/IgM Rapid Test Device Deployed to Global Market

HANGZHOU, China, May 11, 2020 /PRNewswire/ -- On April 20,2020, Chinese People's Association for Friendship with Foreign Countries(CPAFFC) deployed a batch of anti-epidemic materials manufactured by Hangzhou Realy Tech Co. Ltd. and donated them toBangladesh, Morocco, Malaysia and Thailand. A numb...

2020-05-11 14:12 2632

Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing

NEW YORK and BALLINA, Ireland, May 11, 2020 /PRNewswire/ -- Technopath Clinical Diagnostics today launched its Multichem ID-COVID-19 Quality Control Solutions offering laboratories third-party quality control products enabling an independent, totally unbiased assessment of a diagnostic device or ...

2020-05-11 14:00 3216

Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker

SEOUL, South Korea, May 11, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) unveiled for the first time the phase 3 clinical data of Fexuprazan, a novel gastroesophageal reflux disease agent at Digestive Disease Week (DDW) 2020. The abstract of Fexuprazan has been rated in the top 10% pos...

2020-05-11 08:00 5291

United Imaging delivered twelve mobile DR systems to support Ukraine in fight against COVID-19

SHANGHAI, May 9, 2020 /PRNewswire/ -- United Imaging, an innovation solution provider for advanced medical imaging and radiotherapy equipment, confirmed that the first batch of 12 mobile digital radiography (DR) systems has arrived inUkraine and is now being installed in 11 hospitals across 9 cit...

2020-05-09 20:00 1842

HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance

HANGZHOU, China, May 8, 2020 /PRNewswire/ -- HJB, a biologics CDMO committed to quality, reliability and speed for each and every CMCpackage delivered to its partners, today announces that its partner Mabspace Biosciences has received Investigational New Drug (IND) clearance from both the U.S. Fo...

2020-05-08 23:00 1942

Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea

* Following the US FDA's IND clearance, South Korea's MFDS cleared the IND application of BBT-176, submitted inDecember 2019 * BBT-176 will be the company's first drug candidate to launch clinical studies inSouth Korea * In the second half of this year, the company is expected to initiate a ...

2020-05-08 07:30 1682

Scientific Evidence Shows Everyday Hygiene Is Essential to Help Prevent the Spread of Infections, Reveals New Paper From The Global Hygiene Council

LONDON, May 8, 2020 /PRNewswire/ -- According to a new Position Paper published in theAmerican Journal of Infection Control  online, improved everyday hygiene practices, such as handwashing, can help to significantly reduce the ...

2020-05-08 07:01 3770

VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update

AUSTIN, Texas, May 7, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quarter endedMarch 31, 2020. Volition management will host a conference call tomorrow,May 8 at 8:30 a.m. U.S. Eastern Time to disc...

2020-05-08 04:10 10139
1 ... 571572573574575576577 ... 610

Week's Top Stories